Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rickenbach

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Plos One|January 12, 2012
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapyTracy R Glass, Margalida Rotger, Amalio Telenti, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovirViktor von Wyl, Sabine Yerly, Jürg Böni, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Journal of the International AIDS Society|November 14, 2014
Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort StudyKaroline Aebi-Popp, Roger Kouyos, Barbara Bertisch, et al.
Archives of Internal Medicine|September 12, 2007
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen typesViktor von Wyl, Sabine Yerly, Jürg Böni, et al.
Antiviral Therapy|December 15, 2010
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study, Rainer Weber, Caroline Sabin, et al.
Antiviral Therapy|July 21, 2004
Infrequent transmission of HIV-1 drug-resistant variantsSabine Yerly, Stéphanie Jost, Amalio Telenti, et al.
Antiviral Therapy|December 1, 2005
Predictors of hypertension and changes of blood pressure in HIV-infected patientsRodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller, et al.
Archives of Internal Medicine|August 16, 2006
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D studyRainer Weber, Caroline A Sabin, Nina Friis-Møller, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Plos One|January 12, 2012
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapyTracy R Glass, Margalida Rotger, Amalio Telenti, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovirViktor von Wyl, Sabine Yerly, Jürg Böni, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Journal of the International AIDS Society|November 14, 2014
Loss to follow-up of HIV-infected women after delivery: The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort StudyKaroline Aebi-Popp, Roger Kouyos, Barbara Bertisch, et al.
Archives of Internal Medicine|September 12, 2007
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen typesViktor von Wyl, Sabine Yerly, Jürg Böni, et al.
Antiviral Therapy|December 15, 2010
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study, Rainer Weber, Caroline Sabin, et al.
Antiviral Therapy|July 21, 2004
Infrequent transmission of HIV-1 drug-resistant variantsSabine Yerly, Stéphanie Jost, Amalio Telenti, et al.
Antiviral Therapy|December 1, 2005
Predictors of hypertension and changes of blood pressure in HIV-infected patientsRodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller, et al.
Archives of Internal Medicine|August 16, 2006
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D studyRainer Weber, Caroline A Sabin, Nina Friis-Møller, et al.
Pageof 7